ProPhase Labs, Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
ProPhase Labs, Inc. (PRPH) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $1.02 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2026-08-19
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-09-30 was $0.00.
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-06-30 was $0.00.
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-03-31 was $2.45.
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-09-30 was -$0.09.
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2025 was $1.02.
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2024 was -$1.92.
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was -$0.02.
- ProPhase Labs, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2020 was $0.02.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.02 10-K · filed 2026-06-01 | ||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-19 | $0.22 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | $2.25 10-Q · filed 2026-08-19 | $0.23 10-Q · filed 2025-08-13 | ||||
| 2025-03-31 | $2.45 10-Q/A · filed 2026-07-09 | $0.25 10-Q · filed 2025-05-20 | |||||
| 2024-12-31 | -$1.92 10-K · filed 2026-06-01 | -$0.19 10-K · filed 2025-04-01 | |||||
| 2024-09-30 | -$0.09 10-Q · filed 2025-11-19 | -$0.16 10-Q · filed 2025-11-19 | |||||
| 2024-06-30 | -$0.04 10-Q · filed 2025-08-13 | -$0.08 10-Q · filed 2025-08-13 | |||||
| 2024-03-31 | -$0.04 10-Q · filed 2025-05-20 | ||||||
| 2023-12-31 | -$0.02 10-K · filed 2025-04-01 | ||||||
| 2020-12-31 | $0.02 10-K · filed 2022-03-31 | ||||||
| 2020-09-30 | $0.01 10-Q · filed 2020-11-19 | $0.01 10-Q · filed 2020-11-19 | |||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 | ||||||
| 2018-09-30 | -$0.01 10-Q · filed 2019-11-12 | -$0.01 10-Q · filed 2019-11-12 | |||||
| 2017-09-30 | -$0.05 10-Q/A · filed 2018-08-20 | $2.45 10-Q/A · filed 2018-08-20 | |||||
| 2017-06-30 | -$0.14 10-Q/A · filed 2018-08-20 | $2.44 10-Q/A · filed 2018-08-20 | |||||
| 2017-03-31 | $2.57 10-Q/A · filed 2018-08-20 | $2.61 10-Q · filed 2017-05-15 | |||||
| 2016-03-31 | -$0.08 10-Q/A · filed 2018-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |